Multimodal AI in Biomedicine: Pioneering the Future of Biomaterials, Diagnostics, and Personalized Healthcare

Multimodal artificial intelligence (AI) is driving a paradigm shift in modern biomedicine by seamlessly integrating heterogeneous data sources such as medical imaging, genomic information, and electronic health records. This review explores the transformative impact of multimodal AI across three pivotal areas: biomaterials science, medical diagnostics, and personalized medicine. In the realm of biomaterials, AI facilitates the design of patient-specific solutions tailored for tissue engineering, drug delivery, and regenerative therapies. Advanced tools like AlphaFold have significantly improved protein structure prediction, enabling the creation of biomaterials with enhanced biological compatibility. In diagnostics, AI systems synthesize multimodal inputs combining imaging, molecular markers, and clinical data-to improve diagnostic precision and support early disease detection. For precision medicine, AI integrates data from wearable technologies, continuous monitoring systems, and individualized health profiles to inform targeted therapeutic strategies. Despite its promise, the integration of AI into clinical practice presents challenges such as ensuring data security, meeting regulatory standards, and promoting algorithmic transparency. Addressing ethical issues including bias and equitable access remains critical. Nonetheless, the convergence of AI and biotechnology continues to shape a future where healthcare is more predictive, personalized, and responsive.